ClassID:

96898

C07K14/47 - page 6 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Recent Application in this class:
#1501
20200010518
2020-01-09

Immunogenic fragment peptide of EN2 protein or antibody composition specifically recognizing same

#1502
20200009236
2020-01-09

H3.3 CTL peptides and uses thereof

#1503
20200009063
2020-01-09

FORMULATIONS OF GUANYLATE CYCLASE C AGONISTS AND METHODS OF USE

#1504
20200002710
2020-01-02

Systems and methods for control of gene expression

#1505
20200002390
2020-01-02

Htt repressors and uses thereof

#1506
20200002389
2020-01-02

Transdermal peptide with nuclear localization ability and use thereof

#1507
20200000905
2020-01-02

Heat shock protein-binding peptide compositions and methods of use thereof

#1508
20200000902
2020-01-02

Peptides and combination of peptides for use in immunotherapy against various cancers

#1509
20200000900
2020-01-02

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#1510
20190390186
2019-12-26

Compositions and methods for identifying RNA binding polypeptide targets

#1511
20190389922
2019-12-26

Peptides for angiogenic therapy

#1512
20190382746
2019-12-19

Artificial ribosomes for fully programmable synthesis of nonribosomal peptides

#1513
20190382455
2019-12-19

Fusion molecules

#1514
20190381184
2019-12-19

Methods and compositions for reducing metastases

#1515
20190381153
2019-12-19

Botulinum neurotoxins with modified light chain specificity and methods for producing same

#1516
20190381132
2019-12-19

METHODS AND COMPOSITIONS FOR TREATMENT OF IONIZING RADIATION RESISTANT TUMORS

#1517
20190376064
2019-12-12

Genetic and pharmacological transcriptional upregulation of the repressed FXN gene as a therapeutic strategy for Friedreich ataxia

#1518
20190376039
2019-12-12

CELLS WITH IMPROVED INWARD RECTIFIER CURRENT

#1519
20190376030
2019-12-12

REGULATORY T CELL POPULATIONS

#1520
20190375850
2019-12-12

EFFECTIVE GENERATION OF TUMOR-TARGETED T CELLS DERIVED FROM PLURIPOTENT STEM CELLS

#1521
20190375843
2019-12-12

COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES

#1522
20190375810
2019-12-12

Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen species

#1523
20190375806
2019-12-12

Method of treating breast cancer

#1524
20190375805
2019-12-12

NAF-1 derived peptides and uses thereof

#1525
20190374763
2019-12-12

ULTRASOUND-SENSING PROTEINS AND METHOD FOR STIMULATING CELLS BY ULTRASOUND

#1526
20190374626
2019-12-12

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#1527
20190374604
2019-12-12

Therapeutic compositions

#1528
20190374575
2019-12-12

Ex vivo antigen-presenting cells or activated CD-positive T cells for treatment of cancer

#1529
20190367572
2019-12-05

Methods for treatment of erectile dysfunction with sonic hedgehog compounds

#1530
20190367568
2019-12-05

CALRETICULIN AND FUSION PROTEINS

#1531
20190365874
2019-12-05

COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING FIBROSIS, SYSTEMIC SCLEROSIS, SCLERODERMA AND GRAFT VERSUS HOST DISEASE

#1532
20190365844
2019-12-05

Methods of increasing muscle mass by administration of activin type 2 receptor antibodies

#1533
20190365793
2019-12-05

CENTRAL NERVOUS SYSTEM TARGETING POLYNUCLEOTIDES

#1534
20190359669
2019-11-28

Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof

#1535
20190359663
2019-11-28

Liver-type fatty acid-binding protein standard, method for evaluating standard, method for regulating variation range of measured value caused by liver-type fatty acid-binding protein in measurement using standard, liver-type fatty acid-binding protein, DNA encoding protein, cell transformed by DNA, method of producing protein, method of drawing calibration curve for liver-type fatty acid-binding protein, and method of quantifying protein

#1536
20190358297
2019-11-28

ANGIOGENIC CONDITIONING TO ENHANCE CARDIAC CELLULAR REPROGRAMMING OF FIBROBLASTS OF THE INFARCTED MYOCARDIUM

#1537
20190353655
2019-11-21

Identification, selection and use of high curative potential T cell epitopes

#1538
20190352689
2019-11-21

Methods and compositions for making vault particles in yeast

#1539
20190352380
2019-11-21

COMPOSITIONS TARGETING THE SOLUBLE EXTRACELLULAR DOMAIN OF E-CADHERIN AND RELATED METHODS FOR CANCER THERAPY

#1540
20190352353
2019-11-21

Methods and compositions for delivering interleukin-1 receptor antagonist

#1541
20190352352
2019-11-21

Methods of processing ß-lactoglobulin-containing compositions with thermolysin and transglutaminase

#1542
20190352351
2019-11-21

Dual inhibitory action peptidomimetic inhibitor for IL-33 and IL-1beta

#1543
20190352341
2019-11-21

MODIFIED PEPTIDES AND THEIR USE FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

#1544
20190351373
2019-11-21

Organic solvent method for preparing membrane protein based nanosheets and membranes based on nanosheets

#1545
20190351036
2019-11-21

REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF

#1546
20190346453
2019-11-14

Sensors and assays for ubiquitin or ubiquitin-like proteins

#1547
20190345208
2019-11-14

Methods and compositions for treating hemophilia

#1548
20190345207
2019-11-14

Lipocalin muteins with binding affinity for LAG-3

#1549
20190345206
2019-11-14

Engineered Fc constructs

#1550
20190345195
2019-11-14

Preparation of recombinant tetrameric N-acetylated alpha-synuclein

#1551
20190343920
2019-11-14

AAV-MEDIATED GENE THERAPY FOR NPHP5 LCA-CILIOPATHY

#1552
20190338361
2019-11-07

Inhibiting the onset of gout

#1553
20190338273
2019-11-07

Method to overcome DNA chemical modifications sensitivity of engineered TALE DNA binding domains

#1554
20190338020
2019-11-07

IL-31 ANTIBODY COMPOSITIONS

#1555
20190338002
2019-11-07

Proteins specific for calcitonin gene-related peptide

#1556
20190338001
2019-11-07

Composition Containing SMAD Protein for Treatment of Autoimmune Diseases, a Fusion Protein Comprising SMAD Protein, an Expression Vector and a Method for Preparing the Same

#1557
20190338000
2019-11-07

Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof

#1558
20190337999
2019-11-07

Modification and compositions of human secretoglobin proteins

#1559
20190336784
2019-11-07

SYSTEMS, METHODS AND COMPOSITIONS FOR OPTICAL STIMULATION OF TARGET CELLS

#1560
20190336618
2019-11-07

Intrathecal delivery of recombinant adeno-associated virus 9

#1561
20190336589
2019-11-07

IMMUNIZING PEPTIDE, METHOD FOR PRODUCING IMMUNIZING PEPTIDE, PHARMACEUTICAL COMPOSITION FOR IMMUNE DISEASE CONTAINING SAME, AND METHOD FOR TREATING IMMUNE DISEASE

#1562
20190331695
2019-10-31

Reagents and methods for detecting protein lysine 3-hydroxybutyrylation

#1563
20190330613
2019-10-31

CONTROL OF PROTEIN TO PROTEIN INTERACTIONS OF ACID DECARBOXYLASE

#1564
20190330289
2019-10-31

GENERATION OF BRAIN AND SPINAL CORD NEURONS, CARDIAC MYOCYTES, RENAL NEPHRONS AND HEPATOCYTES USING REG PEPTIDES, PEPTIDOMIMETICS, SMALL MOLECULES AND STIMULATORY ANTIBODIES TO REG RECEPTOR

#1565
20190330288
2019-10-31

Methods for enhancing the pluripotency of stem cells

#1566
20190328855
2019-10-31

Optimized Synthetic Consensus Immunogenic Compositions Targeting Fibroblast Activation Protein

#1567
20190328801
2019-10-31

Microorganism for delivering drug for treatment of gastrointestinal disease, which expresses and secretes P8 protein, and pharmaceutical composition for preventing or treating gastrointestinal disease, which includes the same

#1568
20190323031
2019-10-24

Non-meiotic allele introgression

#1569
20190322755
2019-10-24

CAR expression vector and CAR-expressing T cells

#1570
20190322729
2019-10-24

COMPOSITIONS AND METHODS RELATED TO K180 DIMETHYLATED H1.0 PROTEIN

#1571
20190321405
2019-10-24

Immunotherapy against neuronal and brain tumors

#1572
20190316154
2019-10-17

ERYTHROID-SPECIFIC PROMOTER AND METHOD OF USE THEREOF

#1573
20190315824
2019-10-17

Modified polynucleotides for the production of secreted proteins

#1574
20190315820
2019-10-17

A Composition Containing SMAD Protein for Treatment of Autoimmune Diseases, a Fusion Protein Comprising SMAD Protein, an Expression Vector and a Method for Preparing the Same

#1575
20190315819
2019-10-17

Peptide directed protein knockdown

#1576
20190315799
2019-10-17

Scalable production of genetically engineered nanofibrous macroscopic materials via filtration

#1577
20190314527
2019-10-17

In vivo production of proteins

#1578
20190314490
2019-10-17

Stabilized influenza hemagglutinin stem region trimers and uses thereof

#1579
20190314476
2019-10-17

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

#1580
20190314475
2019-10-17

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

#1581
20190314421
2019-10-17

NUCLEIC ACID CONSTRUCTS INCLUDING A TXNIP PROMOTER FOR THE TREATMENT OF DISEASE

#1582
20190310249
2019-10-10

Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis

#1583
20190309050
2019-10-10

Fusion protein Slit2D2(C386S)-HSA and use thereof in treatment of fibrotic diseases

#1584
20190309039
2019-10-10

CRYPTIC POLYPEPTIDES AND USES THEREOF

#1585
20190309032
2019-10-10

Recombinant protein-based method for the delivery of silencer RNA to target the brain

#1586
20190307842
2019-10-10

Methods for treating bone loss using sclerostin peptides

#1587
20190300911
2019-10-03

METHODS FOR INCREASING THE FREQUENCY OF GENE TARGETING BY CHROMATIN MODIFICATION

#1588
20190300595
2019-10-03

Peptides and combination of peptides for use in immunotherapy against various tumors

#1589
20190298821
2019-10-03

Nucleic Acids for Treatment of Peanut Allergies

#1590
20190298747
2019-10-03

Methods for treatment of cancer by targeting SIRT5

#1591
20190298658
2019-10-03

Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis

#1592
20190292276
2019-09-26

Internalizing moieties

#1593
20190292241
2019-09-26

GDF15 fusion proteins and uses thereof

#1594
20190287691
2019-09-19

Separation of metal ions by liquid-liquid extraction

#1595
20190284269
2019-09-19

Methods for treatment of cancer comprising TIGIT-binding agents

#1596
20190284255
2019-09-19

PROGRAMMABLE IMMUNOCYTE RECEPTOR COMPLEX SYSTEM

#1597
20190284249
2019-09-19

BETA-CATENIN BARCODED PEPTIDES

#1598
20190282625
2019-09-19

Methods for enhancing lifespan and/or treating cellular proliferative disorders by transplantation

#1599
20190277867
2019-09-12

Application of artificially expressed HSP27 protein in detecting a residue of a β2-adrenergic receptor agonist-based drug

#1600
20190276891
2019-09-12

GENE FOR IDENTIFYING INDIVIDUALS WITH FAMILIAL DYSAUTONOMIA

#1601
20190276508
2019-09-12

Method of purification of recombinant osteopontin from micro algae

#1602
20190275131
2019-09-12

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#1603
20190275130
2019-09-12

Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)

#1604
20190271705
2019-09-05

SH2 DOMAIN VARIANTS

#1605
20190270800
2019-09-05

Production cell line enhancers

#1606
20190269798
2019-09-05

Intrathecal delivery of recombinant adeno-associated virus 9

#1607
20190269767
2019-09-05

Peptides and combination of peptides for use in immunotherapy against various cancers

#1608
20190265244
2019-08-29

Compounds and Methods Useful for Detection and Treatment of Cancer

#1609
20190263912
2019-08-29

Modulation of intestinal epithelial cell differentiation, maintenance and/or function through T cell action

#1610
20190263899
2019-08-29

Compositions, methods, and therapeutic uses related to fusogenic protein minion

#1611
20190263878
2019-08-29

Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides

#1612
20190263869
2019-08-29

Recombinant binding proteins and their use

#1613
20190262474
2019-08-29

Intrathecal delivery of recombinant adeno-associated virus 9

#1614
20190262444
2019-08-29

Peptides and combination of peptides for use in immunotherapy against various cancers

#1615
20190262368
2019-08-29

Antibodies specific for LOX1 and use in treatment of cardiovascular disorders

#1616
20190256567
2019-08-22

Compositions and methods for diagnosing and/or treating kidney injury

#1617
20190254972
2019-08-22

Preparation method of adiposomes, and use thereof

#1618
20190248912
2019-08-15

ABCG2 monoclonal antibody and uses thereof

#1619
20190248872
2019-08-15

Fc FUSION PROTEINS COMPRISING NOVEL LINKERS OR ARRANGEMENTS

#1620
20190248870
2019-08-15

NOVEL a4ß7 PEPTIDE DIMER ANTAGONISTS

#1621
20190248848
2019-08-15

SYNTHETIC TRANSCRIPTIONAL REGULATOR COMPOSITIONS AND METHODS

#1622
20190248846
2019-08-15

MITOCHONDRIAL PROTEINS CONSTRUCTS AND USES THEREOF

#1623
20190242907
2019-08-08

Serologic assay of liver fibrosis

#1624
20190241959
2019-08-08

Nucleic acids, methods and kits for the diagnosis of DYT6 primary torsion dystonia

#1625
20190241673
2019-08-08

Synthetic peptide, relative artificial antigen, relative anti-EHD2 antibody and preparation method thereof and use thereof

#1626
20190241622
2019-08-08

Protein secretory production method

#1627
20190241621
2019-08-08

Secretory production method for protein

#1628
20190241613
2019-08-08

Structure-based peptide inhibitors of alpha-synuclein aggregation

#1629
20190240594
2019-08-08

Channeled fibers in separation of biologically active nanoparticles

#1630
20190240351
2019-08-08

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS

#1631
20190240305
2019-08-08

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#1632
20190240289
2019-08-08

Tear lipocalin muteins binding IL-4 r alpha

#1633
20190234948
2019-08-01

Compositions and methods related to the methylation of histone H1.0 protein

#1634
20190233506
2019-08-01

Human Anti-Tau Antibodies

#1635
20190233501
2019-08-01

Methods and compositions relating to covalently circularized nanodiscs

#1636
20190233498
2019-08-01

Anti-PACAP antibodies and uses thereof

#1637
20190233484
2019-08-01

KIDNEY DISEASE TARGETS AND USES THEREOF

#1638
20190233483
2019-08-01

Antimicrobial peptides based on CMAP27

#1639
20190225667
2019-07-25

Inducible caspases and methods for use

#1640
20190225661
2019-07-25

Compositions and methods for vascular protection against reperfusion injury after myocardial ischemia

#1641
20190225660
2019-07-25

METHOD OF TREATING AND PREVENTING OCULAR ANGIOGENESIS

#1642
20190225645
2019-07-25

Method for preparing a complete protein and uses thereof

#1643
20190224339
2019-07-25

COMPOSITIONS FOR THE TREATMENT OF DISEASE

#1644
20190224277
2019-07-25

BIO-MIMETIC FORMULATION

#1645
20190224241
2019-07-25

Nonviral minicircle vector carrying SOX gene and construction method therefor

#1646
20190219575
2019-07-18

Cellular vamp cleavage assay

#1647
20190218522
2019-07-18

Chimeric poxvirus compositions and uses thereof

#1648
20190218279
2019-07-18

PAC1 antibodies and uses thereof

#1649
20190218269
2019-07-18

Triple glucagon/GLP-1/GIP receptor agonist

#1650
20190218260
2019-07-18

Methods for enhancing immune responsiveness in an individual toward a target cancer cell population comprising apoptotic cells

#1651
20190218259
2019-07-18

Compositions and methods for brown fat induction and activity using FNDC5

#1652
20190216947
2019-07-18

Nanocage and use thereof

#1653
20190216890
2019-07-18

Compositions, methods and uses comprising teneurin C-terminal associated peptide -1 (TCAP-1) for enhancing muscle performance

#1654
20190212346
2019-07-11

Development and use of fluorescent probes of unbound bilirubin

#1655
20190211359
2019-07-11

RNA virus vectors carrying DAI and RIPK3

#1656
20190211114
2019-07-11

Method of inhibiting the enzymatic activity of vascular endothelial lipase with a monoclonal antibody

#1657
20190211069
2019-07-11

Nucleic acids for single-domain antibodies with thermal stability under cytoplasmic expression

#1658
20190211068
2019-07-11

Single-domain antibody fusion proteins with the acid tail of alpha-synuclein

#1659
20190211062
2019-07-11

Modified proteins and methods of use thereof

#1660
20190210005
2019-07-11

Compositions and methods for selectively sequestering metal ions

#1661
20190203210
2019-07-04

Increasing ATOH1 life to drive sensorineural hair cell differentiation

#1662
20190203188
2019-07-04

Fusion proteins and methods thereof

#1663
20190202894
2019-07-04

Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR

#1664
20190201510
2019-07-04

PASSIVE VACCINE FOR ELIMINATION OF SENESCENT CELLS

#1665
20190201496
2019-07-04

BLOCKADE OF ALPHAFETOPROTEIN (AFP) INTERACTIONS WITH BETA2-MICROGLOBULIN ASSOCIATED MOLECULES

#1666
20190201487
2019-07-04

NNIF and nNIF-related peptides and related methods

#1667
20190201483
2019-07-04

ATF5 peptide variants and uses thereof

#1668
20190195896
2019-06-27

Antibodies to TTR and methods of use

#1669
20190195893
2019-06-27

Methods and compositions for diagnosing brain injury or neurodegeneration

#1670
20190195863
2019-06-27

Embryonic cell-based therapeutic candidate screening systems, models for Huntington's Disease and uses thereof

#1671
20190194753
2019-06-27

Methods and compositions for screening and treating developmental disorders

#1672
20190194687
2019-06-27

EFFICIENT NON-MEIOTIC ALLELE INTROGRESSION IN LIVESTOCK

#1673
20190194669
2019-06-27

UTRs increasing the translation efficiency of RNA molecules

#1674
20190194646
2019-06-27

RAPID AND SIMPLIFIED DEVELOPING ANTIBODIES AND FABs OR OTHER MOLECULES CONSISTING OF AMINO ACIDS RECOGNIZING NATURAL ANTIGENS OR NON-NATURAL MOLECULAR TARGETS USING SPECIAL BLOCKING AGENT

#1675
20190194275
2019-06-27

MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications

#1676
20190194270
2019-06-27

Specific active site inhibitors of enzymes or substrate binding partners and methods of producing same

#1677
20190185552
2019-06-20

Use of regulatory T cell-specific surface protein LRIG-1

#1678
20190185540
2019-06-20

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#1679
20190185530
2019-06-20

Complex-specific standardization of immunological methods for the quantification of S100A12

#1680
20190185529
2019-06-20

SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES

#1681
20190185527
2019-06-20

Scorpion toxin fusion protein with enhanced skin cell proliferation effect and cosmetic composition for anti-wrinkle, enhancing skin elasticity and anti-aging comprising the same as an effective ingredient

#1682
20190184041
2019-06-20

Chelating platform for delivery of radionuclides

#1683
20190184013
2019-06-20

COMPOSITIONS FOR SELECTIVE HUMORAL RESPONSES AND METHODS OF USE THEREOF

#1684
20190183994
2019-06-20

Regulatory T cell epitopes, compositions and uses thereof

#1685
20190183993
2019-06-20

Regulatory T cell epitopes, compositions and uses thereof

#1686
20190177410
2019-06-13

Fusion protein comprising apelin and an anti-APLNR antibody

#1687
20190175712
2019-06-13

Cancer vaccines targeting LEMD1 and uses thereof

#1688
20190175517
2019-06-13

Polynucleotides encoding citrin for the treatment of Citrullinemia type 2

#1689
20190170754
2019-06-06

Method and reagent for detecting ovarian clear cell adenocarcinoma

#1690
20190169581
2019-06-06

Human serum albumin binding compounds and fusion proteins thereof

#1691
20190169258
2019-06-06

Method of protecting tissue from damage by administering a bi-specific therapeutic protein comprising insulin-like growth factor 1 (IGF-1) and Annexin A5

#1692
20190169248
2019-06-06

Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2

#1693
20190169244
2019-06-06

Compositions and methods for enhancing visual function

#1694
20190169231
2019-06-06

Compositions containing HC-HA/PTX3 complexes and methods of use thereof

#1695
20190168444
2019-06-06

Method for producing gelatin formed body and gelatin formed body

#1696
20190167760
2019-06-06

Polypeptides binding to human complement C5

#1697
20190161527
2019-05-30

Peptides and compositions for treatment of joint damage

#1698
20190160186
2019-05-30

Materials and methods for treatment of friedreich ataxia and other related disorders

#1699
20190160163
2019-05-30

Preparation of flagellin vaccine adjuvant-based vaccine to induce production of antibody recognizing conformation of antigens, and application thereof

#1700
20190160160
2019-05-30

Methods to Treat Diseases with Protein, Peptide and Antigen Modification

#1701
20190160123
2019-05-30

Oncolytic expression vector comprising a nucleic acid comprising a nucleotide sequence encoding GADD34

#1702
20190153406
2019-05-23

MG53 mutants, methods of making the same, and uses thereof

#1703
20190153060
2019-05-23

Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonist

#1704
20190153056
2019-05-23

Methods and compositions relating to p62/SQSTM1 for the treatment and prevention of inflammation-associated diseases

#1705
20190153050
2019-05-23

Dual-AAV vector-based systems and methods for delivering oversized genes to mammalian cells

#1706
20190151477
2019-05-23

Intrathecal delivery of recombinant adeno-associated virus 9

#1707
20190151428
2019-05-23

Vaccine compositions comprising an amphipathic compound, a neoantigen and a hydrophobic carrier, and methods of use thereof

#1708
20190151410
2019-05-23

Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptide

#1709
20190144513
2019-05-16

Core domain of annexins and uses thereof in antigen delivery and vaccination

#1710
20190142919
2019-05-16

PLIF MULTIMERIC PEPTIDES AND USES THEREOF

#1711
20190136283
2019-05-09

Modification of RNA-related enzymes for enhanced production

#1712
20190134226
2019-05-09

INTRATHECAL DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS 9

#1713
20190134225
2019-05-09

Intrathecal delivery of recombinant Adeno-associated virus 9

#1714
20190134223
2019-05-09

Methods for treating heart failure using beta-ARKnt peptide

#1715
20190134170
2019-05-09

Composition comprising PCSK9 peptide conjugated to a Qbeta carrier and methods of using the same

#1716
20190134156
2019-05-09

Tissue protective peptides for preventing and treating diseases and disorders associated with tissue damage

#1717
20190133964
2019-05-09

Polypeptide nano-bubbles and preparation method and application thereof

#1718
20190133173
2019-05-09

Method using slit-robo system to treat sarcopenia

#1719
20190127804
2019-05-02

Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer

#1720
20190127730
2019-05-02

Engineered FHA domains

#1721
20190127443
2019-05-02

Multivalent heteromultimer scaffold design and constructs

#1722
20190127441
2019-05-02

Methods and compositions for reducing infectivity of virus particles comprising an ERGIC-53 polypeptide

#1723
20190127439
2019-05-02

Engineered PD-1 variants

#1724
20190127434
2019-05-02

Method for producing TLR5 agonist protein

#1725
20190125900
2019-05-02

Expression of neuropeptides

#1726
20190119656
2019-04-25

Truncated Constructs Related To RIPK3

#1727
20190119352
2019-04-25

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#1728
20190119351
2019-04-25

Peptides and combination of peptides for use in immunotherapy against various tumors

#1729
20190119344
2019-04-25

Control system and method for tapered structure construction

#1730
20190119339
2019-04-25

NOVEL HUMAN ULIP/CRMP PROTEIN AND USE THEREOF IN DIAGNOSIS AND TREATMENT OF CANCERS AND PARANEOPLASTIC NEUROLOGICAL SYNDROMES

#1731
20190119338
2019-04-25

COMPOSITIONS AND METHODS FOR OLIGODENDROCYTE DEVELOPMENT

#1732
20190119337
2019-04-25

Methods of treating mitochondrial disorders

#1733
20190119225
2019-04-25

Heterocyclic compound

#1734
20190117793
2019-04-25

MODULAR NANODEVICES FOR SMART ADAPTABLE VACCINES

#1735
20190117729
2019-04-25

GJA1 isoforms protect against metabolic stress

#1736
20190117688
2019-04-25

Compositions comprising secreted extracellular vesicles of cells expressing NFATC4 useful for the treatment of cancer

#1737
20190112663
2019-04-18

Cornulin (CRNN) variants and uses thereof

#1738
20190112384
2019-04-18

COMPOSITIONS AND METHODS FOR THE DETECTION DIAGNOSIS AND THERAPY OF HEMATOLOGICAL MALIGNANCIES

#1739
20190112338
2019-04-18

Decoy peptides inhibiting protein phosphatase 1-medicated dephosphorylation of phospholamban

#1740
20190111146
2019-04-18

HIV peptide vaults and methods of making and using thereof

#1741
20190111135
2019-04-18

Compositions and their use for controlling the nervous system in vivo

#1742
20190111120
2019-04-18

NOVEL CANCER ANTIGEN EEF2

#1743
20190111115
2019-04-18

Recombinant intravenous immunoglobulin (rIVIG) compositions and methods for their production and use

#1744
20190106708
2019-04-11

Efficient non-meiotic allele introgression in livestock

#1745
20190106484
2019-04-11

ANTIBODY AGAINST PEPTIDE ENCODED BY EXON-21 OF PERIOSTIN AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATION-ASSOCIATED DISEASES CONTAINING THE SAME

#1746
20190106469
2019-04-11

Over-expression of AZF1 improves the rate of anaerobic xylose fermentation in engineered yeast strains

#1747
20190106468
2019-04-11

Wnt/sFRP complexes, Wnt-containing compositions, Wnt-expressing cells, and methods of making, purifying, and using same

#1748
20190106463
2019-04-11

Engineered polypeptides for antigen delivery

#1749
20190101528
2019-04-04

LIPOCALIN FUSION PARTNERS

#1750
20190100761
2019-04-04

COMPOSITIONS AND METHODS FOR ENHANCED GENE EXPRESSION AND VIRAL REPLICATION

#1751
20190099503
2019-04-04

INTRATHECAL DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS 9

#1752
20190092874
2019-03-28

NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 161P2F10B USEFUL IN TREATMENT AND DETECTION OF CANCER

#1753
20190092837
2019-03-28

Prion protein-dendrimer conjugates for use in treatment of alzheimer disease

#1754
20190092817
2019-03-28

FUNCTIONAL LIGANDS TO PEPTIDES

#1755
20190091311
2019-03-28

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#1756
20190091294
2019-03-28

Polypeptides and analogues thereof for use in the treatment of diabetes and bone disorders

#1757
20190091150
2019-03-28

POROUS NANOPARTICLE-SUPPORTED LIPID BILAYERS (PROTOCELLS) FOR TARGETED DELIVERY AND METHODS OF USING SAME

#1758
20190086425
2019-03-21

Diagnostic for sjorgen's syndrome based on a biomarker

#1759
20190085041
2019-03-21

Secretory protein

#1760
20190085040
2019-03-21

Peptide modulators of specific calcineurin protein-protein interactions

#1761
20190084970
2019-03-21

Strigolactone formulations and uses thereof

#1762
20190083580
2019-03-21

Use of endostatin peptides for the treatment of fibrosis

#1763
20190083570
2019-03-21

Peptides with anti-cancer activity

#1764
20190077829
2019-03-14

Methods and compositions to increase the rate of ligation reactions catalyzed by a sortase

#1765
20190076542
2019-03-14

C3-carbon linked glutarimide degronimers for target protein degradation

#1766
20190076476
2019-03-14

Immunotherapy against neuronal and brain tumors

#1767
20190071731
2019-03-07

Methods of identifying a polypeptide target for degradation by a modulator of CRBN

#1768
20190071692
2019-03-07

Promoter

#1769
20190071520
2019-03-07

Method for diagnosing alzheimer's disease using signal peptide as indicator

#1770
20190071476
2019-03-07

Opsin polypeptides and methods of use thereof

#1771
20190071475
2019-03-07

Nanospheres of SEC14-like proteins and cognate ligands

#1772
20190070301
2019-03-07

Activated polyoxazolines and conjugates and compositions comprising the same

#1773
20190070275
2019-03-07

NEOANTIGEN COMPOSITIONS AND METHODS OF USING THE SAME IN IMMUNOONCOTHERAPY

#1774
20190070259
2019-03-07

Methods and compositions for preventing or treating cancer

#1775
20190062420
2019-02-28

Fc γ RIII binding fibronectin type III domains, their conjugates and multispecific molecules comprising them

#1776
20190062385
2019-02-28

Compositions and methods for treatment of disorders related to CEP290

#1777
20190062380
2019-02-28

Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof

#1778
20190060487
2019-02-28

Compositions and methods useful in treating Stargardt's disease and other ocular disorders

#1779
20190060433
2019-02-28

KIF20A EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAME

#1780
20190060398
2019-02-28

USE OF LINGO-4 ANTAGONISTS IN THE TREATMENT OF CONDITIONS INVOLVING DEMYELINATION

#1781
20190055578
2019-02-21

DELIVERY OF CENTRAL NERVOUS SYSTEM TARGETING POLYNUCLEOTIDES

#1782
20190055293
2019-02-21

METHODS TO PRODUCE ROD-DERIVED CONE VIABILITY FACTOR (RDCVF)

#1783
20190054160
2019-02-21

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#1784
20190049454
2019-02-14

Methods for the diagnosis and treatment of gastrointestinal stromal tumors

#1785
20190048074
2019-02-14

Method for treating pathological angiogenesis by administering an antibody that inhibits APLNR

#1786
20190048049
2019-02-14

CARGOMERS

#1787
20190048048
2019-02-14

FUSION PROTEINS AND METHODS FOR IDENTIFYING BROMODOMAIN INHIBITING COMPOUNDS

#1788
20190038729
2019-02-07

Cancer vaccines and methods of treatment using the same

#1789
20190038715
2019-02-07

Peptides derived from actin-like protein 8 (ACTL8)

#1790
20190038712
2019-02-07

Methods of treatment using hemopexin compositions

#1791
20190038707
2019-02-07

Adenovirus-associated viral vectors for expressing variants of tetratricopeptide repeat (TPR)-containing Rab8b interacting (TRIP8b) protein in neurons and uses thereof for treating major depressive disorder (MDD)

#1792
20190033306
2019-01-31

RECURRENT FUSION GENES IN HUMAN CANCERS

#1793
20190031735
2019-01-31

VEGF antagonist formulations suitable for intravitreal administration

#1794
20190031731
2019-01-31

BIGLYCAN VARIANT POLYPEPTIDES AND METHODS OF USE

#1795
20190031729
2019-01-31

Muteins of human tear lipocalin capable of binding lymphocyte-activation gene 3 (LAG-3) and methods of use thereof

#1796
20190031711
2019-01-31

Colostrum solid extraction process

#1797
20190030189
2019-01-31

DELIVERY OF POLYNUCLEOTIDES USING RECOMBINANT AAV9

#1798
20190030144
2019-01-31

Regulatory T cell epitopes, compositions and uses thereof

#1799
20190030143
2019-01-31

Regulatory T cell epitopes, compositions and uses thereof

#1800
20190030134
2019-01-31

Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages